NewAmsterdam Total Assets vs Non Currrent Assets Other Analysis
| NAMSW Stock | 8.90 0.12 1.33% |
NewAmsterdam Pharma financial indicator trend analysis is infinitely more than just investigating NewAmsterdam Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NewAmsterdam Pharma is a good investment. Please check the relationship between NewAmsterdam Pharma Total Assets and its Non Currrent Assets Other accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewAmsterdam Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.
Total Assets vs Non Currrent Assets Other
Total Assets vs Non Currrent Assets Other Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NewAmsterdam Pharma Total Assets account and Non Currrent Assets Other. At this time, the significance of the direction appears to have very strong relationship.
The correlation between NewAmsterdam Pharma's Total Assets and Non Currrent Assets Other is 0.83. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of NewAmsterdam Pharma, assuming nothing else is changed. The correlation between historical values of NewAmsterdam Pharma's Total Assets and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of NewAmsterdam Pharma are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Total Assets i.e., NewAmsterdam Pharma's Total Assets and Non Currrent Assets Other go up and down completely randomly.
Correlation Coefficient | 0.83 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Total Assets
Total assets refers to the total amount of NewAmsterdam Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in NewAmsterdam Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Most indicators from NewAmsterdam Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NewAmsterdam Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewAmsterdam Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.At this time, NewAmsterdam Pharma's Tax Provision is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 31.9 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 1.90 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 216K | 271K | 6.8M | 7.1M | Depreciation And Amortization | 4.4K | 8.4K | 49K | 51.5K |
NewAmsterdam Pharma fundamental ratios Correlations
Click cells to compare fundamentals
NewAmsterdam Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.